Co-expression of TNFR2 and CD25 identifies more of the functional CD4 +FOXP3+ regulatory T cells in human peripheral blood

European Journal of Immunology

Volumn 40, Issue 4, 2010, Pages 1099-1106

  Chen, Xin ^a   Subleski, Jeffrey J ^b   Hamano, Ryoko ^b   Howard, O M Zack ^b   Wiltrout, Robert H ^b   Oppenheim, Joost J ^b  

^a SAIC FREDERICK INC   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

CD25; Human regulatory T cells; Peripheral blood; TNFR2

Indexed keywords

CD4 ANTIGEN; CD45RO ANTIGEN; CHEMOKINE RECEPTOR CCR4; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 7 RECEPTOR; TRANSCRIPTION FACTOR FOXP3;

ARTICLE; AUTOIMMUNE DISEASE; BLOOD; CELL CULTURE; CELL PROLIFERATION; COCULTURE; CONTROLLED STUDY; CYTOKINE PRODUCTION; FLOW CYTOMETRY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE;

ADULT; ANTIGEN PRESENTATION; ANTIGENS, CD; ANTIGENS, CD45; CELLS, CULTURED; COCULTURE TECHNIQUES; FLOW CYTOMETRY; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; IMMUNOPHENOTYPING; INTERFERON-GAMMA; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; INTERLEUKIN-7 RECEPTOR ALPHA SUBUNIT; LYMPHOCYTE ACTIVATION; RECEPTORS, ANTIGEN, T-CELL; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE II; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, REGULATORY;

EID: 77951077218     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.200940022     Document Type: Article

References (32)

1. Sakaguchi, S., Sakaguchi, N., Asano, M., Itoh, M. and Toda, M., Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J. Immunol. 1995. 155: 1151-1164.
2. Sakaguchi, S., Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self. Nat. Immunol. 2005. 6: 345-352.
3. Josefowicz, S. Z. and Rudensky, A., Control of regulatory T cell lineage commitment and maintenance. Immunity 2009. 30: 616-625.
4. Tran, D. Q. and Shevach, E. M., Therapeutic potential of Foxp3(+) regulatory T cells and their interactions with dendritic cells. Hum. Immunol. 2009. 70: 294-299.
5. Brusko, T. M., Putnam, A. L. and Bluestone, J. A., Human regulatory T cells: role in autoimmune disease and therapeutic opportunities. Immunol. Rev. 2008. 223: 371-390.
6. Baecher-Allan, C., Brown, J. A., Freeman, G. J. and Hafler, D. A., CD4+ CD25 high regulatory cells in human peripheral blood. J. Immunol. 2001. 167: 1245-1253.
7. Baecher-Allan, C., Viglietta, V. and Hafler, D. A., Inhibition of human CD4(+)CD25(+high) regulatory T cell function. J. Immunol. 2002. 169: 6210-6217.
8. Wang, J., Ioan-Facsinay, A., van der Voort, E. I., Huizinga, T.W. and Toes, R. E., Transient expression of Foxp3 in human activated nonregulatory CD4+ T cells. Eur. J. Immunol. 2007. 37: 129-138.
9. Liu, W., Putnam, A. L., Xu-Yu, Z., Szot, G. L., Lee, M. R., Zhu, S., Gottlieb, P. A. et al., CD127 expression inversely correlates with Foxp3 and suppressive function of human CD4+ T reg cells. J. Exp. Med. 2006. 203: 1701-1711.
10. Baecher-Allan, C., Wolf, E. and Hafler, D. A., MHC class II expression identifies functionally distinct human regulatory T cells. J. Immunol. 2006. 176: 4622-4631.
11. Ruprecht, C. R., Gattorno, M., Ferlito, F., Gregorio, A., Martini, A., Lanzavecchia, A. and Sallusto, F., Coexpression of CD25 and CD27 identifies Foxp3+ regulatory T cells in inflamed synovia. J. Exp. Med. 2005. 201: 1793-1803.
12. Seddiki, N., Santner-Nanan, B., Tangye, S. G., Alexander, S. I., Solomon, M., Lee, S., Nanan, R. and Fazekas de Saint Groth, B., Persistence of naive CD45RA+ regulatory T cells in adult life. Blood 2006. 107: 2830-2838.
13. Seddiki, N., Santner-Nanan, B., Martinson, J., Zaunders, J., Sasson, S., Landay, A., Solomon, M. et al., Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cells. J. Exp. Med. 2006. 203: 1693-1700.
14. Annunziato, F., Cosmi, L., Liotta, F., Lazzeri, E., Manetti, R., Vanini, V., Romagnani, P., Maggi, E. and Romagnani, S., Phenotype, localization, and mechanism of suppression of CD4(+)CD25(+) human thymocytes. J. Exp. Med. 2002. 196: 379-387.
15. Chen, X., Subleski, J. J., Kopf, H., Howard, O. M., Mannel, D. N. and Oppenheim, J. J., Cutting edge: expression of TNFR2 defines a maximally suppressive subset of mouse CD4+CD25+Foxp3+ T regulatory cells: applicability to tumor-infiltrating T regulatory cells. J. Immunol. 2008. 180: 6467-6471.
16. Chen, X., Baumel, M., Mannel, D. N., Howard, O. M. and Oppenheim, J. J., Interaction of TNF with TNF receptor type 2 promotes expansion and function of mouse CD4+CD25+ T regulatory cells. J. Immunol. 2007. 179: 154-161. (Pubitemid 46986529)
17. Shi, Z., Okuno, Y., Rifa'i, M., Endharti, A. T., Akane, K., Isobe, K. and Suzuki, H., Human CD8+CXCR3+ T cells have the same function as murine CD81CD1221 Treg. Eur. J. Immunol. 2009. 39: 2106-2119.
18. van Mierlo, G. J., Scherer, H. U., Hameetman, M., Morgan, M. E., Flierman, R., Huizinga, T.W. and Toes, R. E., Cutting edge: TNFR-shedding by CD4+ CD25+ regulatory T cells inhibits the induction of inflammatory mediators. J. Immunol. 2008. 180: 2747-2751.
19. Chen, X., Winkler-Pickett, R. T., Carbonetti, N. H., Ortaldo, J. R., Oppenheim, J. J. and Howard, O. M., Pertussis toxin as an adjuvant suppresses the number and function of CD4+CD25+ T regulatory cells. Eur. J. Immunol. 2006. 36: 671-680.
20. Chen, X., Oppenheim, J. J. and Howard, O. M., BALB/c mice have more CD4+CD25+ T regulatory cells and show greater susceptibility to suppression of their CD41CD25- responder T cells than C57BL/6 mice. J. Leukoc. Biol. 2005. 78: 114-121.
21. Friedline, R. H., Brown, D. S., Nguyen, H., Kornfeld, H., Lee, J., Zhang, Y., Appleby, M. et al., CD4+ regulatory T cells require CTLA-4 for the maintenance of systemic tolerance. J. Exp. Med. 2009. 206: 421-434.
22. Wing, K., Onishi, Y., Prieto-Martin, P., Yamaguchi, T., Miyara, M., Fehervari, Z., Nomura, T. and Sakaguchi, S., CTLA-4 control over Foxp3+ regulatory T cell function. Science 2008. 322: 271-275.
23. Curiel, T. J., Coukos, G., Zou, L., Alvarez, X., Cheng, P., Mottram, P., Evdemon-Hogan, M. et al., Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nat. Med. 2004. 10: 942-949.
24. Thornton, A. M. and Shevach, E. M., CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J. Exp. Med. 1998. 188: 287-296.
25. Rudd, C. E., CTLA-4 co-receptor impacts on the function of Treg and CD8+ T-cell subsets. Eur. J. Immunol. 2009. 39: 687-690.
26. Aggarwal, B. B., Signalling pathways of the TNF superfamily: a double-dged sword. Nat. Rev. Immunol. 2003. 3: 745-756.
27. Kim, E. Y., Priatel, J. J., Teh, S. J. and Teh, H. S., TNF receptor type 2 (p75) functions as a costimulator for antigen-driven T cell responses in vivo. J. Immunol. 2006. 176: 1026-1035.
28. Kim, E. Y. and Teh, H. S., TNF type 2 receptor (p75) lowers the threshold of T cell activation. J. Immunol. 2001. 167: 6812-6820.
29. Kim, E. Y. and Teh, H. S., Critical role of TNF receptor type-2 (p75) as a costimulator for IL-2 induction and T cell survival: a functional link to CD28. J. Immunol. 2004. 173: 4500-4509.
30. Minigo, G.,Woodberry, T., Piera, K. A., Salwati, E., Tjitra, E., Kenangalem, E., Price, R. N. et al., Parasite-dependent expansion of TNF receptor II-positive regulatory T cells with enhanced suppressive activity in adults with severe malaria. PLoS Pathog. 2009. 5: e1000402.
31. Hoffmann, P., Eder, R., Boeld, T. J., Doser, K., Piseshka, B., Andreesen, R. and Edinger, M., Only the CD45RA+ subpopulation of CD4+CD25high T cells gives rise to homogeneous regulatory T-cell lines upon in vitro expansion. Blood 2006. 108: 4260-4267.
32. Miyara, M., Yoshioka, Y., Kitoh, A., Shima, T.,Wing, K., Niwa, A., Parizot, C. et al., Functional delineation and differentiation dynamics of human CD41 T cells expressing the Foxp3 transcription factor. Immunity 2009. 30: 899-911.